-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on UiPath, Lowers Price Target to $12

Benzinga·06/29/2026 16:45:11
Listen to the news
UBS analyst Radi Sultan maintains UiPath (NYSE:PATH) with a Neutral and lowers the price target from $13 to $12.